Liposidomycin A
Liposidomycin A exhibits antibacterial properties, though its activity is relatively weak. It demonstrates significant inhibitory effects on mycobacteria, with a minimum inhibitory concentration (MIC) of 0.16 μg/mL. Additionally, Liposidomycin A inhibits glycopeptide biosynthesis, effectively suppressing Escherichia coli glycopeptide biosynthesis with an IC50 of 0.03 μg/mL.
Product Specifications
CAS Number
99751-55-0
Field of Research
Infectious Disease & Virology
Smiles
C (O[C@H]1[C@H] (OS (=O) (=O) O) [C@H] (O) [C@@H] (CN) O1) ([C@H]2O[C@H] ([C@H] (O) [C@@H]2O) N3C (=O) NC (=O) C=C3) C4N (C) CC (OC (CC (OC (CC (CC (O) =O) C) =O) CCCC=CCC=CCCCCC) =O) C (C (O) =O) N (C) C4=O
Molecular Formula
C44H67N5O21S
Molecular Weight
1034.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1721705 3x 1.0 µg
PRKCDBP sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
MBS952233-01 0.02 mg (E-Coli)
Recombinant Human Cholecystokinin (CCK)
Sign In for Pricing
View Details MBS952233-02 0.1 mg (E-Coli)
Recombinant Human Cholecystokinin (CCK)
Sign In for Pricing
View Details MBS952233-03 0.02 mg (Yeast)
Recombinant Human Cholecystokinin (CCK)
Sign In for Pricing
View Details MBS952233-04 0.1 mg (Yeast)
Recombinant Human Cholecystokinin (CCK)
Sign In for Pricing
View Details